Henry I. Miller


Henry I. Miller, MS, MD, was the Robert Wesson Fellow in Scientific Philosophy and Public Policy at the Hoover Institution. His research focused on public policy toward science and technology, encompassing a number of areas, including pharmaceutical development, genetic engineering in agriculture, models for regulatory reform, and the emergence of new viral diseases.

Miller served for fifteen years at the US Food and Drug Administration (FDA) in a number of posts. He was the medical reviewer for the first genetically engineered drugs to be evaluated by the FDA and thus instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner and the founding director of the FDA's Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the US government. As a government official, Miller received numerous awards and citations.

During his time at the Hoover Institution, Miller has become well known not only for his contributions to scholarly journals but also for his articles and books that make science, medicine, and technology accessible. His work has been widely published in many languages. Monographs include Policy Controversy in Biotechnology: An Insider's View; To America's Health: A Model for Reform of the Food and Drug Administration; and The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution. Barron's selected The Frankenfood Myth as one of the 25 Best Books of 2004. In addition, Miller has published extensively in a wide spectrum of scholarly journals and popular publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, the Guardian, Defining Ideas, and the Financial Times. He was a regulator contributor to Forbes.com and frequently appeared on the nationally syndicated radio programs of John Batchelor and Lars Larson.

Miller was selected by the editors of Nature Biotechnology as one of the people who had made the "most significant contributions" to biotechnology during the previous decade. He serves on numerous editorial boards.

Filter By:



Recent Commentary

Analysis and Commentary

UN Bashing is Hardly Enough

by Henry I. Millervia TCS Daily
Monday, June 19, 2006

United Nations deputy secretary-general Mark Malloch Brown has a singular view of what constitutes international diplomacy…

Analysis and Commentary

Save the World, Dump the U.N.

by Henry I. Millervia National Review Online
Thursday, June 15, 2006

Claudia Rosett’s superb NRO piece offers example after example of corruption and profligacy at the U.N…

Analysis and Commentary

Un-diplomacy at the U.N.

by Henry I. Millervia Washington Times
Sunday, June 11, 2006

United Nations Deputy Secretary-General Mark Malloch Brown has a singular view of what constitutes diplomacy…

Analysis and Commentary

A Dose of Common Sense

by Henry I. Millervia National Review Online
Monday, June 5, 2006

It has been said that California is a decade ahead of the rest of the country in adopting new ideas…

Scary Food

by Henry I. Miller, Gregory Conkovia Policy Review
Thursday, June 1, 2006

Fear of biotech may get you sick

Analysis and Commentary

No Apologies

by Henry I. Millervia National Review Online
Friday, May 26, 2006

In their recent article on NRO, Bob Goldberg and Peter Pitts took issue with a previous article published on NRO written by me, criticizing the FDA…

Analysis and Commentary

Biopharm Thrilla in Manila

by Henry I. Millervia TCS Daily
Wednesday, May 24, 2006

Fruits and flowers are not the only things blooming in the tropics…

Analysis and Commentary

Doctor Throws The Book At Gore, Opting For The Psychiatrist's Bible

by Henry I. Millervia Investor's Business Daily
Tuesday, May 23, 2006

I thought we weren't going to have Al Gore to kick around any more…

this is an image

What to Expect from the Avian Flu

by Henry I. Millervia Hoover Digest
Sunday, April 30, 2006

Ready or not, her it comes. Henry I. Miller tells us what we need to know about the avain flu.

Making Sense of Drug Labeling

by Henry I. Millervia Hoover Digest
Monday, January 30, 2006

How the FDA makes medicine labels incomprehensible—and what’s good, and bad, about the newest proposals for reform. By Henry I. Miller.